Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Aquestive Therapeutics, Inc. (AQST)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| BRAENDER LORI J (SVP, General Counsel) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 75,000 rights
@ $0 |
|
| 08/09/2023 |
4
| Barber Daniel (President and CEO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 223,500 rights
@ $0 |
|
| 08/09/2023 |
4
| Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 75,000 rights
@ $0 |
|
| 08/09/2023 |
4
| Boyd Peter E. (See Remark) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 50,000 rights
@ $0 |
|
| 08/09/2023 |
4
| Kraus Carl N (Chief Medical Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 08/09/2023 |
4
| Wargacki Stephen (SVP, Research & Development) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 67,500 rights
@ $0 |
|
| 08/09/2023 |
4
| TOTH A ERNEST JR (SVP, CFO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 70,000 rights
@ $0 |
|
| 08/09/2023 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 50,000 rights
@ $0 |
|
| 08/09/2023 |
4
| Jung Cassie (SVP, Operations) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 55,000 rights
@ $0 |
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| BRAENDER LORI J (SVP, General Counsel) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 75,000 rights
@ $0 |
|
| 05/05/2023 |
4
| Barber Daniel (President and CEO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 223,500 rights
@ $0 |
|
| 05/05/2023 |
4
| Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 75,000 rights
@ $0 |
|
| 05/05/2023 |
4
| Jung Cassie (SVP, Operations) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 55,000 rights
@ $0 |
|
| 05/05/2023 |
4
| Boyd Peter E. (See Remark) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 50,000 rights
@ $0 |
|
| 03/09/2023 |
4
| Boyd Peter E. (See Remark) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 03/09/2023 |
4
| Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 03/09/2023 |
4
| Jung Cassie (SVP, Operations) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 110,000 shares
@ $0 |
|
| 03/09/2023 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 03/09/2023 |
4
| Barber Daniel (President and CEO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 447,000 shares
@ $0 |
|
| 03/09/2023 |
4
| BRAENDER LORI J (SVP, General Counsel) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 03/09/2023 |
4
| Wargacki Stephen (SVP, Research & Development) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 135,000 shares
@ $0 |
|
| 03/09/2023 |
4
| TOTH A ERNEST JR (SVP, CFO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 140,000 shares
@ $0 |
|
| 11/08/2022 |
4
| Boyd Peter E. (SVP-Bus. Process & Info. Tech.) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.875, valued at
$21.9k
|
|
| 11/08/2022 |
4
| BRAENDER LORI J (SVP, General Counsel) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.875, valued at
$35k
|
|
| 11/08/2022 |
4
| Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.875, valued at
$35k
|
|
| 11/08/2022 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.875, valued at
$35k
|
|
| 11/08/2022 |
4
| TOTH A ERNEST JR (SVP, CFO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.875, valued at
$35k
|
|
| 09/08/2022 |
4
| Truitt Kenneth (Chief Medical Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.25, valued at
$125k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| Barber Daniel (President and CEO) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.88, valued at
$88k
|
|
| 06/24/2022 |
4
| Cochran John (Director) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.7132, valued at
$17.8k
|
|
|
|
|